2 hours ago
GSK shares dive as weaker sales and mounting costs unnerve investors
What's happening
SignalsMonitor is following this as a markets story. The Guardian Business is the outlet attached so far. The first report grouped here was at 28 Oct 2026, 12:44 UTC. 2 material updates are listed in the timeline. The headline in use is “GSK shares dive as weaker sales and mounting costs unnerve investors”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
British pharma company reports declining profits amid concerns over looming patent loss for blockbuster HIV drug Business live – latest updates Shares in GSK slid on Wednesday despite the UK drugmaker reporting better than expected financial results, as investors were unnerved by weaker vaccine sales, restructuring charges and its overall…
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by The Guardian Business
GSK shares dive as weaker vaccine sales and restructuring charges unnerve investors
- Picked up by The Guardian Business
GSK shares dive as weaker sales and mounting costs unnerve investors
Reported by 1 outlet
- The Guardian